A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Will Savage, MD PhD
Disc Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Phoenix, Arizona, United States
Jeanne Palmer, M.D.Recruiting - Ucla Health
Los Angeles, California, United States
Gary Schiller, M.D.Recruiting - Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
Caitlin O'NeillRecruiting - Keck Medicine of Usc - Cancer Clinic- Newport Beach
Newport Beach, California, United States
Caitlin O'NeillRecruiting - Mayo Clinic in Florida
Jacksonville, Florida, United States
Candido Rivera, M.D.Recruiting - Mayo Clinic in Minnesota
Rochester, Minnesota, United States
Naseema Gangat, M.B.B.S.Recruiting - Siteman Cancer Center - Washington University St. Louis
St Louis, Missouri, United States
Stephen OhRecruiting - Atrium Health - Levine Cancer Center
Charlotte, North Carolina, United States
Anne WoffordMichael GrunwaldRecruiting - Duke University
Durham, North Carolina, United States
Lindsay Rein, MDRecruiting - Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Anne WoffordRecruiting - Cleveland Clinic
Cleveland, Ohio, United States
Aaron Gerds, MDRecruiting - Ohio State University
Columbus, Ohio, United States
Jennifer E Vaughn, MDRecruiting - Oregon Health & Science University
Portland, Oregon, United States
Joseph ShatzelRecruiting - Md Anderson Cancer Center
Houston, Texas, United States
Naveen Pemmaraju, M.D.Recruiting - University of Washington - Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Anna HalpernRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Aug 2025
- Primary completion
- 28 Feb 2027
- Completion
- 28 Feb 2029
- Last update posted
- 28 May 2026
- Registered enrollment
- 60
- Registry id
- NCT06985147
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.